Amyloid precursor protein modulates the interaction of nerve growth factor with p75 receptor and potentiates its activation of trkA phosphorylation

Molecular Brain Research

Volumn 56, Issue 1-2, 1998, Pages 125-132

  Akar, Candan A ^a   Wallace, William C ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Amyloid precursor protein; Nerve growth factor; Neurotrophic activity; Receptor

Indexed keywords

AMYLOID PRECURSOR PROTEIN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BINDING SITES; CELL LINE; DRUG SYNERGISM; ENZYME ACTIVATION; HUMANS; KIDNEY; NERVE GROWTH FACTORS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR;

ANIMALIA;

EID: 0032077567     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00037-0     Document Type: Article

References (49)

1. Barbacid M. Nerve growth factor: a tale of two receptors. Oncogene. 8:1993;2033-2042.
2. Battleman D.S., Geler A.I., Chao M.V. HSV-1 vector mediated gene transfer of the nerve growth factor receptor p75hNGFR defines high affinity NGF binding. J. Neurosci. 13:1993;941-951.
3. Berg M.M., Sternberg D.W., Hempstead B.L., Chao M.V. The low affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation. Proc. Natl. Acad. Sci U.S.A. 88:1993;7106-7110.
4. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci. 18:1995;223-253.
5. Breen K.C., Bruce M., Anderton B.H. Beta-amyloid precursor protein mediates neuronal cell-cell and cell surface adhesion. J. Neurosci. Res. 28:1991;90-100.
6. Chandler C.E., Parsons L.M., Hosang M., Shooter E.M. A monoclonal antibody modulates the interaction of nerve growth factor with PC12 cells. J. Biol. Chem. 259:1984;6882-6889.
7. Chen M., Yankner B.A. An antibody to B-amyloid and the amyloid precursor protein inhibits cell substratum adhesion in many mammalian cell types. Neurosci. Lett. 125:1991;223-226.
8. de Sauvage F., Octave J.N. A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science. 245:1989;651-653.
9. Esch F.S., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., Ward P.J. Cleavage of amyloid B-peptide during constitutive processing of its precursor. Science. 248:1990;1122-1124.
10. Gargano N., Levi A., Alema S. Modulation of nerve growth factor internalization by direct interaction between p75 and TrkA receptors. J. Neurosci. Res. 50:1997;1-12.
11. Gnahn H., Hefti F., Heumann R., Schwab M.E., Theonen H. NGF mediated increase of choline acetyltransferase (ChAT) in the neonatal forebrain: evidence for a physiological role of NGF? Brain Res. 285:1983;45-52.
12. Grob P.M., Ross A.H., Koprowski H., Bothwell M. Characterization of the human melanoma nerve growth factor receptor. J. Biol. Chem. 260:1985;8044-8049.
13. Hefti F., Dravid A., Hartikka J. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 293:1984;305-311.
14. Hempstead B.L., Martin-Zanca D., Kaplan D.R., Parada L.F., Chao M.V. High affinity NGF binding requires coexpression of the trk proto-oncogene and the low affinity NGF receptor. Nature. 350:1991;678-683.
15. Jing S., Tapley P., Barbacid M. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron. 9:1992;1067-1079.
16. Kaplan D.R., Hempstead B.L., Martin-Zanca D., Chao M.V., Parada L.F. F The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science. 252:1991;554-557.
17. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory properties. Nature. 331:1988;530-532.
18. Klein R., Jing S.Q., Nanduri V., O'Rourke E., Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell. 65:1991;189-197.
19. Klier F.G., Cole G., Stallcup W., Schubert D. Amyloid B protein precursor is associated with extracellular matrix. Brain Res. 515:1990;336-342.
20. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1161.
21. Loeb D.M., Greene L.A. Transfection with trk restores 'slow' NGF binding, efficient NGF uptake, and multiple NGF responses to NGF nonresponsive PC12 cell mutants. J. Neurosci. 13:1993;2919-2929.
22. trk. J. Biol. Chem. 269:1994;6884-6891.
23. Mattson M., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intraneuronal calcium regulating roles for secreted forms of the B-amyloid precursor protein. Neuron. 10:1993;243-254.
24. Meakin S.O., Shooter E.M. Tyrosine kinase activity coupled to the high-affinity nerve growth factor-receptor complex. Proc. Natl. Acad. Sci. USA. 88:1991;5862-5866.
25. Meakin S.O., Shooter E.M. The growth factor family of receptors. Trends Neurosci. 15:1992;323-331.
26. Meakin S.O., Suter U., Drinkwater C.C., Welcher A.A., Shooter E.M. The rat trk proto-oncogene product exhibits properties characteristic of the slow nerve growth factor receptor. Proc. Natl. Acad. Sci. USA. 89:1992;2374-2378.
27. Mills J., Charest D.L., Lam F., Beyreuther K., Ida N., Pelech S.L., Reiner P.B. Regulation of amyloid precursor protein catabolism involves the mitogen activated protein kinase signal transduction pathway. J. Neurosci. 17:1997;9415-9422.
28. Milward E.A., Papadopoulos R., Fuller S.J., Moir R.D., Small D., Beyreuther K., Masters C.L. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron. 9:1992;129-137.
29. Mobley W.C., Rutkowski J.L., Tennekoon G.I., Buchanan K., Johnston M.V. Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science. 229:1985;284-287.
30. Narindrasorasak S., Lowery D., Gonzalez-DeWhitt P., Poorman R.A., Greenberg B., Kisilevski R. High affinity interactions between the Alzheimer's B-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266:1991;12878-12883.
31. Oltersdorf T., Fritz L.C., Schenk D.B., Lieberburg I., Johnson-Wood K.L., Beattie E.C., Ward P.J., Russel W.B., Dovey H.F., Sinha S. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin II. Nature. 341:1989;144-147.
32. Oltersdorf T., Ward P.J., Henriksson T., Beattie E.C., Neve R., Lieberburg I., Fritz L.C. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J. Biol. Chem. 265:1990;4492-4497.
33. Ponte P., Gonzalez-DeWhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W.C., Lieberburg I., Fuller F., Cordell B. A new A4 mRNA contains a domain homologous to serine protease inhibitors. Nature. 331:1988;525-527.
34. Refolo L.M., Salton S.R.J., Anderson J.P., Mehta P., Robakis N.K. Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC12 cell cultures. Biochem. Biophys. Res. Commun. 164:1989;664-670.
35. Saitoh T., Sundsmo M., Roch J.-M., Kimura N., Cole G., Schubert D., Oltersdorf T., Schenk D.B. Secreted form of amyloid B-protein precursor is involved in the growth regulation of fibroblasts. Cell. 58:1989;615-622.
36. Schubert D., Jin L.-W., Saitoh T., Cole G. The regulation of amyloid B protein precursor secretion and its modulatory role in cell adhesion. Neuron. 3:1989;689-694.
37. Schubert D., LaCorbiere M., Saitoh T., Cole G. Characterization of an amyloid B precursor protein that binds heparin and contains tyrosine sulfate. Proc. Natl. Acad. Sci. U.S.A. 86:1989;2066-2069.
38. Sinha S., Dovey H.F., Seubert P., Ward P.J., Blacher R.W., Blaber M., Bradshaw R.A., Arici M., Mobley W.C., Lieberburg I. The protease inhibitory properties of the Alzheimer's B-amyloid precursor protein. J. Biol. Chem. 265:1990;8983-8985.
39. Sisodia S.S., Koo E.H., Beyreuther K., Unterbeck A., Price D.L. Evidence that B-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 248:1990;492-495.
40. Small D.H., Nurcombe V., Reed G., Clarris H., Moir R.D., Beyreuther K., Masters C.L. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J. Neurosci. 14:1994;2117-2127.
41. Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L., Gusella J.F., Neve R.L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 331:1988;528-532.
42. Vale R.D., Shooter E.M. Assaying binding of nerve growth factor to cell surface receptors. Methods Enzymol. 109:1985;21-39.
43. Van Nostrand W.E., Wagner S.L., Suzuki M., Choi B.H., Farrow S., Geddes J.W., Cotman C.W., Cunningham D.D. Protease nexin II, a potent anti-chymotrypsin, shows identity to amyloid B-protein precursor. Nature. 341:1989;546-549.
44. Wallace W.C., Lieberburg I., Schenk D., Vigo-Pelfrey C., Davis K.L., Haroutunian V. Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats. J. Neurosci. 15:1995;4896-4905.
45. Wallace W.C., Akar C.A., Lyons W.E. Amyloid precursor protein potentiates the neurotrophic activity of NGF. Mol. Brain Res. 52:1997;201-212.
46. Wallace W.C., Akar C.A., Lyons W.E., Kole H.K., Egan J.M., Wolozin B. Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity. Mol. Brain Res. 52:1997;213-227.
47. Weidemann A., König G., Bunke D., Fischer P., Salbaum M.J., Masters C.L., Beyreuther K. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell. 57:1989;115-126.
48. Weskamp G., Reichardt L.F. Evidence that biological activity of NGF is mediated through a novel subclass of high affinity receptors. Neuron. 6:1991;649-663.
49. Yuen E.C., Mobley W.C. Therapeutic applications of neurotrophic factors in disorders of motor neurons and peripheral nerves. Mol. Med. Today. 1:1995;278-286.